Discover open access scientific publications

Search, annotate, share and cite publications

Publications by P. Zinzani

90 Y-Ibritumomab Tiuxetan in Patients With Extra-Nodal Marginal Zone B-Cell Lymphoma of Mucosa Associated Lymphoid Tissue (Malt Lymphoma) - The Zeno Study

Hematological Oncology

English

Ct-P10 Rapid Infusion in Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukaemia: Interim Results From a Non-Interventional Post-Authorisation Safety Study

Hematological Oncology

English

Phase 1b Study of Pembrolizumab in Patients With Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (Rrpmbcl): Updated Results From the Keynote-013 Trial

Hematological Oncology

English

The Braf Inhibitor Vemurafenib Plus Rituximab Produces a High Rate of Deep and Durable Responses in Relapsed/Refractory Hairy Cell Leukemia: Updated Results of a Phase-2 Trial

Hematological Oncology

English

Response to A+chp by Cd30 Expression in the Echelon-2 Trial

Hematological Oncology

English

Characterization of Duvelisib in Patients With Refractory Marginal Zone Lymphoma: Data From the Phase 2 Dynamo Trial

Hematological Oncology

English

A First-In-Human Trial of the Novel Multi-Action Therapy Tinostamustine (Edo-S101) in Patients With Relapsed/Refractory (R/R) Hodgkin Lymphoma (Hl)

Hematological Oncology

English

Clinical Characteristics of Patients With Negative Interim-Pet and Positive Final Pet: Data From the Prospective Pet-Oriented Hd0801 Study by Fondazione Italiana Linfomi (Fil)

Hematological Oncology

English

Umbralisib Monotherapy Demonstrates Efficacy and Safety in Patients With Relapsed/Refractory Marginal Zone Lymphoma: A Multicenter, Open-Label, Registration Directed Phase 2 Study

Hematological Oncology

English

Treatment Emergent Adverse Events Vary With Different Pi3k Inhibitors

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by P. Zinzani

90 Y-Ibritumomab Tiuxetan in Patients With Extra-Nodal Marginal Zone B-Cell Lymphoma of Mucosa Associated Lymphoid Tissue (Malt Lymphoma) - The Zeno Study

Ct-P10 Rapid Infusion in Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukaemia: Interim Results From a Non-Interventional Post-Authorisation Safety Study

Phase 1b Study of Pembrolizumab in Patients With Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (Rrpmbcl): Updated Results From the Keynote-013 Trial

The Braf Inhibitor Vemurafenib Plus Rituximab Produces a High Rate of Deep and Durable Responses in Relapsed/Refractory Hairy Cell Leukemia: Updated Results of a Phase-2 Trial

Response to A+chp by Cd30 Expression in the Echelon-2 Trial

Characterization of Duvelisib in Patients With Refractory Marginal Zone Lymphoma: Data From the Phase 2 Dynamo Trial

A First-In-Human Trial of the Novel Multi-Action Therapy Tinostamustine (Edo-S101) in Patients With Relapsed/Refractory (R/R) Hodgkin Lymphoma (Hl)

Clinical Characteristics of Patients With Negative Interim-Pet and Positive Final Pet: Data From the Prospective Pet-Oriented Hd0801 Study by Fondazione Italiana Linfomi (Fil)

Umbralisib Monotherapy Demonstrates Efficacy and Safety in Patients With Relapsed/Refractory Marginal Zone Lymphoma: A Multicenter, Open-Label, Registration Directed Phase 2 Study

Treatment Emergent Adverse Events Vary With Different Pi3k Inhibitors